Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLS2901C in Osteoarthritis of the Knee
NCT06549686Phase 3Recruiting
- Sponsor
- CellSeed
- Start
- Oct 2023
- Primary completion
- Dec 2028
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of CLS2901C in knee osteoarthritis (OA), sponsored by CellSeed. Started Oct 2023; status: recruiting.
02
Drugs
CLS2901C
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06549686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06549686.